
Intelligent Bio Solutions (INBS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Intelligent Bio Solutions (INBS) last issued guidance on February 5, 2026 for Q2 2026. The company guided revenue in the range of $899.09K - $899.09K for the period.
Compared to prior guidance, Intelligent Bio Solutions raised its revenue forecast from a prior range of $610K - $610K.
Intelligent Bio Solutions has issued 7 guidance updates between February 2, 2024 and February 5, 2026. During this period, the company raised its outlook 2 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
| Metric | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.58 | — | — | — |
| Actual | $-0.90 | $-1.80 | $-2.82 | $-3.50 |
| Surprise | +43.0% | — | — | — |
| Revenue | ||||
| Estimate | $1.2M | — | — | — |
| Actual | $1.1M | $1.1M | $896774 | $1.1M |
| Surprise | -6.07% | — | — | — |
| Metric | Q1 '27E | Q2 '27E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-1.31 | $-1.36 |
| Revenue | ||
| Consensus | $1.4M | $1.4M |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | Aug 19, 2026 | $-0.90 | $-1.58 | 43.0 % |
| Q1 | Nov 7, 2024 | $-7.00 | $-5.30 | -32.1 % |
| Q3 | May 8, 2024 | $-14.30 | $-25.20 | 43.3 % |
| Q1 | Nov 8, 2023 | $-124.80 | $-76.80 | -62.5 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | Aug 19, 2026 | $1.15M | $1.22M | -6.07 % |
| Q1 | Nov 7, 2024 | $872.29K | $1.75M | -50.2 % |
| Q4 | Sep 19, 2024 | $727.82K | $1.43M | -49.1 % |
| Q3 | May 8, 2024 | $823.80K | $1.08M | -23.7 % |